Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Medlumics S.L.
The Madrid, Spain-based company is developing the AblaView ablation catheter for treating atrial fibrillation.
MedLumics appointed James Greene as its CEO and Giovanni Leo to the board of directors. The Madrid-based company expects the two industry veterans to carry it through the its next phase of growth – commercialization of the AblaView AF catheter.
This week's roundup includes CEO appointments by Gyroscope Therapeutics, Urovant Sciences and Nevoii Pharmaceuticals, in addition to various other high-level appointments by companies including, Horizon Pharma, Veloxis Pharmaceuticals, Modus Therapeutics and Adherium.
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
- Medical Devices
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Diagnostic Imaging Equipment & Supplies